Cargando…
Anxiety disorders: a review of current literature
Anxiety disorders are the most prevalent psychiatric disorders. There is a high comorbidity between anxiety (especially generalized anxiety disorders or panic disorders) and depressive disorders or between anxiety disorders, which renders treatment more complex. Current guidelines do not recommend b...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573565/ https://www.ncbi.nlm.nih.gov/pubmed/28867933 |
_version_ | 1783259687354892288 |
---|---|
author | Thibaut, Florence |
author_facet | Thibaut, Florence |
author_sort | Thibaut, Florence |
collection | PubMed |
description | Anxiety disorders are the most prevalent psychiatric disorders. There is a high comorbidity between anxiety (especially generalized anxiety disorders or panic disorders) and depressive disorders or between anxiety disorders, which renders treatment more complex. Current guidelines do not recommend benzodiazepines as first-line treatments due to their potential side effects. Selective serotonin reuptake inhibitors and selective serotonin norepinephrine reuptake inhibitors are recommended as first-line treatments. Psychotherapy, in association with pharmacotherapy, is associated with better efficacy. Finally, a bio-psycho-social model is hypothesized in anxiety disorders. |
format | Online Article Text |
id | pubmed-5573565 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Les Laboratoires Servier |
record_format | MEDLINE/PubMed |
spelling | pubmed-55735652017-09-01 Anxiety disorders: a review of current literature Thibaut, Florence Dialogues Clin Neurosci Editorial Anxiety disorders are the most prevalent psychiatric disorders. There is a high comorbidity between anxiety (especially generalized anxiety disorders or panic disorders) and depressive disorders or between anxiety disorders, which renders treatment more complex. Current guidelines do not recommend benzodiazepines as first-line treatments due to their potential side effects. Selective serotonin reuptake inhibitors and selective serotonin norepinephrine reuptake inhibitors are recommended as first-line treatments. Psychotherapy, in association with pharmacotherapy, is associated with better efficacy. Finally, a bio-psycho-social model is hypothesized in anxiety disorders. Les Laboratoires Servier 2017-06 /pmc/articles/PMC5573565/ /pubmed/28867933 Text en Copyright: © 2017 AICH - Servier Research Group. All rights reserved http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Thibaut, Florence Anxiety disorders: a review of current literature |
title | Anxiety disorders: a review of current literature |
title_full | Anxiety disorders: a review of current literature |
title_fullStr | Anxiety disorders: a review of current literature |
title_full_unstemmed | Anxiety disorders: a review of current literature |
title_short | Anxiety disorders: a review of current literature |
title_sort | anxiety disorders: a review of current literature |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573565/ https://www.ncbi.nlm.nih.gov/pubmed/28867933 |
work_keys_str_mv | AT thibautflorence anxietydisordersareviewofcurrentliterature |